Association between Hemoglobin A1c and Renal Arteriolar Sclerosis in Subjects Presenting without any Apparent Kidney Dysfunction

2024-8-1

Impaired Cholesterol Efflux Capacity rather than Low HDL-C Reflects Oxidative Stress under Acute Myocardial Infarction

2024-8-1

Association between Vascular Calcification and Intraplaque Hemorrhage in Coronary Atherosclerosis from Autopsy: The Hisayama Study

2024-8-1

Polygenic Risk Scores in Predicting Coronary Artery Disease in Symptomatic Patients. A Validation Study

2024-7-1

Associations between Supper Timing and Mortality from Cardiovascular Disease among People with and without Hypertension

2024-7-1

Association of Nonalcoholic Fatty Liver Disease with Arterial Stiffness and its Metabolomic Profiling in Japanese Community-Dwellers

2024-7-1

Relationships of Weight Change from 20 Years of Age with the Risks of All-Cause and Cardiovascular Mortality in Patients with Chronic Kidney Disease

2024-7-1

Identification of a Compound Heterozygous LMF1 Variants in a Patient with Severe Hypertriglyceridemia – Case Report and Literature Review

2024-7-1

Assessment Timings of Polygenic Risk Score for Atherosclerotic Cardiovascular Disease

2024-7-1

Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15

2024-6-1

Physicians’ Perspective Toward Hypertensive Disorders of Pregnancy and Future Cardiovascular Diseases in Japan

2024-6-1

Validation of Estimated Small Dense Low-Density Lipoprotein Cholesterol Concentration in a Japanese General Population

2024-6-1

Effect of the Xanthine Oxidase Inhibitor, Febuxostat, on WBC Count in Asymptomatic Hyperuricemia: Subanalysis of the Randomized PRIZE Study

2024-6-1

Cilostazol plus Aspirin vs. Clopidogrel plus Aspirin in Acute Minor Stroke or Transient Ischemic Attack

2024-6-1

Impact of the Japanese Version of High Bleeding Risk Criteria on Clinical Outcomes in Patients with ST-segment Elevation Myocardial Infarction

2024-6-1

Leucocyte Count: Inflammatory and ROS Biomarkers of ASCVD

2024-6-1

Primary Prevention of Coronary and Other Cardiovascular Diseases: A Focused Review

2024-5-31

Importance of Setting Reference Ranges for Serum Lipids by Age or Pubertal Stage in Children and Adolescents

2024-5-23

The Long-Term Prognostic Role of Nighttime Resting Heart Rate in Obstructive Sleep Apnea in Patients with Acute Coronary Syndrome

2024-5-1

Remnant Cholesterol is More Strongly Associated with Arterial Stiffness than Traditional Lipids and Lipid Ratios in the General Chinese Population

2024-5-1

Transitional Medicine of Intractable Primary Dyslipidemias in Japan

2024-5-1

Assessment of Residual Vasospasm in Patients with Plaque Rupture or Plaque Erosion using Optical Coherence Tomography

2024-5-1

Utility of the ACD-GENE-CLI Score in Asian Patients with Critical Limb Ischemia Undergoing Endovascular Interventions

2024-5-1

Association between Myocardial Oxygen Supply and Demand and Myocardial Injury in Patients with End-Stage Kidney Disease

2024-5-1

Association Between Adequate Serum 25(OH)D Levels and Atherogenic Dyslipidemia in Young Adults

2024-5-1

Antihypertensive Drugs Affect the Association of Systolic Blood Pressure Variability with Outcomes in Patients with Acute Stroke who had Successful Recanalization after Endovascular Treatment

2024-5-1

Validation of the 2022 Clinical Diagnostic Criteria of Familial Hypercholesterolemia in Japan

2024-5-1

Cardiovascular Risk Age Reflects Arterial Status: Middle-Aged People Showed Equivalent Arterial Stiffness to Older People in the Same Risk Category

2024-5-1

Which Metabolites are Involved in the Pathogenesis of Atherosclerotic Disease in NAFLD?

2024-4-18

In the Beginning, Lipoproteins Cross the Endothelial Barrier

2024-4-12

Evaluating Total Atherosclerosis Burden of Baroreceptor-Resident Arteries after Ischemic Cerebrovascular Disease for Identifying Patients with Heavy Coronary Atherosclerosis Burden

2024-4-1

The Association between the Level of Ankle-Brachial Index and the Risk of Poor Physical Function in Patients with Cardiovascular Disease

2024-4-1

A Novel Risk Stratification Marker in Patients with Coronary Artery Disease

2024-4-1

Importance of Sustained Control of Multiple Risk Factors and Lifestyle Modifications for Cardiovascular Health

2024-4-1

Prognostic Significance of Soluble PD-L1 on Cardiovascular Outcomes in Patients with Coronary Artery Disease

2024-4-1

Association between an Antioxidant-Rich Japanese Diet and Chronic Kidney Disease: The Ohasama Study

2024-4-1

Impact of Low-Density Lipoprotein Cholesterol Levels at Acute Coronary Syndrome Admission on Long-Term Clinical Outcomes

2024-4-1

New Criteria for Metabolic Syndrome: Evaluation of its Effectiveness and Economy for Screening will be Needed

2024-4-1

Usefulness of New Criteria for Metabolic Syndrome Optimized for Prediction of Cardiovascular Diseases in Japanese

2024-4-1

Association of Cumulative Exposure to Cardiovascular Health Behaviors and Factors with the Onset and Progression of Arterial Stiffness

2024-4-1

Association of Antipsychotic Drugs with Venous Thromboembolism: Data Mining of Food and Drug Administration Adverse Event Reporting System and Mendelian Randomization Analysis

2024-4-1

Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment

2024-4-1

Genetic and Functional Analyses of Patients with Marked Hypo-High-Density Lipoprotein Cholesterolemia

2024-3-27

Alcohol Consumption and Cerebral Small- and Large-Vessel Diseases: A Mendelian Randomization Analysis

2024-2-1

The Prognostic Impact of In-Hospital Major Bleeding and Recurrence of Myocardial Infarction during Acute Phase after Percutaneous Coronary Intervention for Acute Myocardial Infarction

2024-2-1

Alcohol Consumption and Cerebral Small- and Large-Vessel Diseases: A Mendelian Randomization Analysis

2024-2-1

C-Terminal Binding Protein 2 Emerges as a Critical Player Linking Metabolic Imbalance to the Pathogenesis of Obesity

2024-2-1

Central Systolic Blood Pressure as a Risk Factor for Accelerated Progression of Arterial Stiffness

2024-2-1

Longitudinal Changes in Arterial Stiffness Associated with Physical Activity Intensity: The Toon Health Study

2024-2-1

Validation of the Usefulness of the Diameter Reduction, Spiral Shape, Flow Impairment, or Adverse Morphology Classification System in Real-World Clinical Practice

2024-2-1